A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis
Conditions: Bladder Pain Syndrome; Interstitial Cystitis Interventions: Drug: ASP6294; Drug: Placebo Sponsor: Astellas Pharma Europe B.V. Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials